New Subtype of Macrophages Linked to Tumor Response
Author Information
Author(s): Chen Kun, Li Yida, Ni Jianjiao, Yang Xi, Zhou Yue, Pang Yechun, Ye Ruiting, Chen Hongru, Yu Silai, Wang Peng, Zhu Zhengfei
Primary Institution: Fudan University Shanghai Cancer Center
Hypothesis
The study investigates the role of a novel subtype of SPP1+ macrophages expressing SIRPα in tumor immune evasion and treatment response prediction.
Conclusion
A novel subtype of SPP1+ macrophages expressing SIRPα was identified, and their abundance predicted patients' response to PD-1/PD-L1 inhibitors.
Supporting Evidence
- SPP1+ macrophages showed high phagocytic activity and were enriched in tumor tissues.
- High abundance of SPP1+ SIRPα+ macrophages correlated with better responses to PD-1/PD-L1 inhibitors.
- SPP1+ SIRPα+ macrophages were found closer to tumor cells and CD8+ T cells, indicating their active role in the tumor microenvironment.
Takeaway
Scientists found a new type of immune cell that helps tumors hide and can predict how well patients will respond to certain cancer treatments.
Methodology
The study used single-cell RNA sequencing and multiplexed immunohistochemistry to analyze macrophages in various cancer types.
Participant Demographics
240 treatment-naïve, histologically confirmed ESCC patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website